51st week of 2008 patent applcation highlights part 37 |
Patent application number | Title | Published |
20080311154 | COLD-ADAPTED EQUINE INFLUENZA VIRUSES - The present invention provides experimentally-generated cold-adapted equine influenza viruses, and reassortant influenza A viruses comprising at least one genome segment of such an equine influenza virus, wherein the equine influenza virus genome segment confers at least one identifying phenotype of the cold-adapted equine influenza virus, such as cold-adaptation, temperature sensitivity, dominant interference, or attenuation. Such viruses are formulated into therapeutic compositions to protect animals from diseases caused by influenza A viruses, and in particular, to protect horses from disease caused by equine influenza virus. The present invention also includes methods to protect animals from diseases caused by influenza A virus utilizing the claimed therapeutic compositions. Such methods include using a therapeutic composition as a vaccine to generate a protective immune response in an animal prior to exposure to a virulent virus, and using a therapeutic composition as a treatment for an animal that has been recently infected with a virulent virus, or is likely to be subsequently exposed to virulent virus in a few days whereby the therapeutic composition interferes with the growth of the virulent virus, even in the absence of immunity. The present invention also provides methods to produce cold-adapted equine influenza viruses, and reassortant influenza A viruses having at least one genome segment of an equine influenza virus generated by cold-adaptation. | 2008-12-18 |
20080311155 | Strain-Independent Amplification of Pathogens and Vaccines Thereto - This in invention relates to methods for the nucleic acid amplification of multiple variants (strains) of any pathogen present in a sample, and preferably in a sample from a pathogen infected individual. In preferred embodiments, the pathogen is a retrovirus, such as HIV. The amplified pathogen nucleic acid can be used to identify the pathogen variants present in a sample, to quantitate the pathogen present in a sample, and as a nucleic acid vaccine, or in the preparation of antigen presenting cell vaccines. Nucleic acids produced by the methods of the invention or the proteins encoded thereby can be used to transfect/load antigen presenting cells. The loaded antigen presenting cells can then be used as a vaccine for the treatment of pathogen infection. In another embodiment, nucleic acids produced by the methods of the invention can be used directly as nucleic acid vaccines without prior loading into antigen presenting cells. | 2008-12-18 |
20080311156 | VACCINES - The present invention relates to adjuvant compositions which are suitable to be used in vaccines. In particular, the adjuvant compositions of the present invention comprises a saponin and an immunostimulatory oligonucleotide, optionally with a carrier. Also provided by the present invention are vaccines comprising the adjuvants of the present invention and an antigen. Further provided are methods of manufacture of the adjuvants and vaccines of the present invention and their use as medicaments. Methods of treating an individual susceptible to or suffering from a disease by the administration of the vaccines of the present invention are also provided. | 2008-12-18 |
20080311157 | Pharmaceutical Compound Capable of Induce Immune Protective Response Against Dengue Virus Having the Capsid Protein of the Dengue Virus - This invention describe the a pharmaceutical compound having the capsid protein of Dengue virus capable of induce in the receptor a protective immune response before the viral challenge without inducing the Ab-dependent enhancement phenomenon. | 2008-12-18 |
20080311158 | Hepatitis C Virus Replication System - A cell including: (a) a hepatitis C virus genome, and/or nucleic acid encoding a hepatitis C virus genome; and (b) nucleic acid encoding one or both of hepatitis C virus proteins E | 2008-12-18 |
20080311159 | Methods and Means for Diagnostics, Prevention and Treatment of Mycobacterium Infections and Tuberculosis Disease - The invention identifies a narrow subset of | 2008-12-18 |
20080311160 | Clear Pharmaceutical Aqueous Emulsion Composition Which Comprises Propofol and Process for Preparing this Composition - The present invention concerns a clear pharmaceutical aqueous emulsion composition which comprises Propofol and a surfactant system and which is particularly usable for a safe administration through intravenous injection. A composition according to the invention is characterized in that the surfactant system comprises in combination at least one pharmaceutically acceptable monovalent metal salt of a fatty acid having from 5 to 23 carbon atoms, and at least one polyethylene glycol hydroxystearate. This combination allows to use a mass ratio (w/w) surfactant system/Propofol which is less than 4 and preferably less than or equal to 2.8, while obtaining such a clear composition. | 2008-12-18 |
20080311161 | Compositions and Methods for Enhanced Gastrointestinal Stability of Oligopeptides and Polypeptides - Methods and compositions are provided for stabilizing polypeptides for oral administration, particularly where enteric delivery is desirable. By administering the polypeptides with a bile sequestering agent, the stability of the polypeptide can be increased. Pharmaceutical formulations for this purpose are provided. | 2008-12-18 |
20080311162 | Solid form - A solid form comprising at least one film enrobing a compacted fill material comprising a pressure sensitive multiparticulate and at least one cushioning agent, in which the multiparticulate and/or the cushioning agent comprises at least one active material, having low friability and wherein the compacted fill material has a density of at least 0.5 g/ml based on the total solid volume of the solid form and a tensile strength of less than 0.9 MPa. | 2008-12-18 |
20080311163 | Cosmetic Treatment With Nitric Oxide, Device For Performing Said Treatment And Manufacturing Method Therefor - A cosmetic treatment method, and a device therefor, are provided that allow for cosmetic treatment of cosmetic disorders, caused by chronological age, environmental factors, changes in physiological functions of skin, such as psoriasis, dermatitis, acne, cellulites, and viral and/or bacteriological attacks. The device comprises a nitric oxide (NO) eluting polymer arranged to contact the area to be cosmetically treated, such that a cosmetic dose of nitric oxide is eluted from said nitric oxide eluting polymer to said area. The nitric oxide (NO) eluting polymer is integrated with a carrier material, such that said carrier material, in use, regulates and controls the elution of said cosmetic dosage of nitric oxide (NO). Furthermore, a manufacturing method for said device is provided. | 2008-12-18 |
20080311164 | GELLING AGENT - Gelling agents which contain a specific N-acylamino acid monoamide monoalkyl ester have a melting temperature of about 100° C., are capable of solidifying a wide variety of oily base materials including silicones, and do not cause “sweating” while retaining a practical level of gel strength. When applied to skin, the resulting gels have a good feeling, good spreadability, and good fittability to skin. | 2008-12-18 |
20080311165 | Copper Containing Materials for Treating Wounds, Burns and Other Skin Conditions - The invention provides a method for treating and healing sores, cold sores, cutaneous openings, ulcerations, lesions, abrasions, burns and skin conditions comprising applying to a body surface exhibiting the same, a material incorporating water-in-soluble copper compounds which release cu | 2008-12-18 |
20080311166 | COOLING TOWEL - Absorbent cloths (cooling towels) impregnated with a formulation including purified water, denatured alcohol, Aloe vera, menthol, and at least one scented essential oil, have been developed for quickly and conveniently cooling the skin. A typical cooling towel as described herein is made from | 2008-12-18 |
20080311167 | Topical Composition for Treating Pain - Topical compositions having as the active ingredient a lipid, fatty acid ester, natural wax, sterol, or combinations thereof referred to herein as “lipophilic vehicle” or “LV” and methods of use, have been developed for the amelioration or prevention of pain or the sequelae of pain. The composition may be in the form of an ointment, cream, gel, lotion, spray, foam, paste, patch, suspension or dispersion. In the preferred embodiment, the formulation is a gel. The LV may contain a penetration enhancer, most preferably one with membrane disruptive properties. The formulation may be applied to or impregnated into a gauze, wrap, bandage, cotton-tipped stick, adhesive bandage strip, or other support wrap or medical bandage or wound cover. For example, the compositions may be are incorporated onto or into disposables such as hemorrhoid wipes, sponge, mouth guards, dental trays; needles or catheters; adult diapers; gloves, socks or wrist bands, for ease of application. The composition is applied topically to a site at or adjacent to a painful region. The composition is reapplied as necessary. Pain relief is typically obtained within minutes and lasts for periods of variable duration ranging from minutes to several hours and even, in some cases, days. The composition is variably effective to treat visceral, somatic and neuropathic pain both acute and chronic as well as muscle pain and stiffness and joint pain and stiffness. | 2008-12-18 |
20080311168 | PROCESS FOR COMBATING ACARIDS - The invention relates to a novel use of zinc sulfide as agent for combating acarids. The invention also relates to compositions with acarid-combating properties comprising zinc sulfide as additive, in particular polymer compositions, and to yarns, fibers, filaments and articles obtained from these compositions; it is also targeted at liquid or solid compositions for cleaning and/or treating textile surfaces, in particular carpets, including fitted carpets. | 2008-12-18 |
20080311169 | Composition Comprising Ginsenosides for Treating or Preventing Angiostenosis and Restenosis - The present invention relates to use of ginsenoside Rg3, Rg5 or Rk1, or extract of ginseng, red ginseng or processed ginseng comprising the ginsenosides; a composition for preventing or treating angiostenosis and restenosis comprising the ginsenosides or extracts; a method for preventing or treating angiostenosis and restenosis by administrating the ginsenosides or extracts comprising the ginsenosides; and a preparation method of agents for preventing or treating angiostenosis and restenosis. The present composition can effectively prevent or treat angiostenosis and restenosis. | 2008-12-18 |
20080311170 | IMPLANT DEVICE RELEASE AGENTS AND METHODS OF USING SAME - Medical implant devices are prepared from a polymeric material and a release agent, where the device is a molded, reservoir implant, and the release agent has a molecular weight (MW) of at least 1000. The release agent may be a non-ionic surfactant such as Brij 35, polyoxyetheylene(20)sorbitan trioleate, Tween 20, Tween 80, vitamin E TPGS, and a mixture of any two or more thereof. Hydrated implants may have a surface area of about 500 mm | 2008-12-18 |
20080311171 | IMPLANTABLE POLYMERIC DEVICE FOR SUSTAINED RELEASE OF DOPAMINE AGONIST - The present invention provides compositions, methods, and kits for treatment of Parkinson's disease and other conditions for which treatment with a dopamine agonist is therapeutically beneficial. The invention provides a biocompatible nonerodible polymeric device which releases dopamine agonist continuously with generally linear release kinetics for extended periods of time. Dopamine agonist is released through pores that open to the surface of the polymeric matrix in which it is encapsulated. The device may be administered subcutaneously to an individual in need of continuous treatment with dopamine agonist. | 2008-12-18 |
20080311172 | Programmed-release, nanostructured biological construct - A biologically engineered construct comprising of a polymeric biomatrix, designed with a nanophase texture, and a therapeutic agent for the purpose of tissue regeneration and/or controlled delivery of regenerative factors and therapeutic substances after it is implanted into tissues, vessels, or luminal structures within the body. The therapeutic agent may be a therapeutic substance or a biological agent, such as antibodies, ligands, or living cells. The nanophase construct is designed to maximize lumen size, promote tissue remodeling, and ultimately make the implant more biologically compatible. The nano-textured polymeric biomatrix may comprise one or more layers containing therapeutic substances and/or beneficial biological agents for the purpose of controlled, differential substance/drug delivery into the luminal and abluminal surfaces of the vessel or lumen, and the attraction of target molecules/cells that will regenerate functional tissue. The topographic and biocompatible features of this layered biological construct provides an optimal environment for tissue regeneration along with a programmed-release, drug delivery system to improve physiological tolerance of the implant, and to maximize the cellular survival, migration, and integration within the implanted tissues. | 2008-12-18 |
20080311173 | IMPLANTABLE OR INSERTABLE MEDICAL DEVICES FOR CONTROLLED DELIVERY OF A THERAPEUTIC AGENT - The present invention is directed to novel implantable or insertable medical devices that provide release of a therapeutic agent. According to a first aspect of the present invention, a therapeutic-agent-releasing medical device is provided, which comprises: (a) an implantable or insertable medical device; (b) a release layer disposed over at least a portion of the implantable or insertable medical device, and (c) a therapeutic agent. The release layer regulates the rate of release of the therapeutic agent from the medical device upon implantation or insertion of the device into a patient. The release layer comprises (i) a first polymer comprising one or more polymer chains that form one or more polymer phase domains when the first polymer is in a pure solid-state form; and (ii) a second polymer comprising two or more polymer chains that form two or more phase domains when the second polymer is in a pure solid-state form. The first and second polymers are preferably selected such that at least one polymer chain in the second polymer is compatible with at least one polymer chain in the first polymer. The present invention is also directed to methods of forming the above implantable or insertable medical devices, methods of administering a therapeutic agent to a patient using such devices, and methods of modulating the release of therapeutic agents from implantable or insertable medical devices. | 2008-12-18 |
20080311174 | Food and Process for Producing Food - The present invention retains the original shape, color, taste, flavor and texture, suppresses liquating out nutritional contents, can easily adjust the hardness of a food, can efficiently manufacture a processed food which uses a wide variety of food materials, can preserve by suppressing microbial deterioration due to its hygienic manufacture, and can easily and manufacture a processed food in a short period of time, wherein the food is capable of supplying nutritious substance according to need. The method of manufacturing a food of the present invention including bringing either one or both of a thickener in a non-solvated state and microorganism which generates a viscous material into contact with the surface of a food material, and performing a pressure treatment, such that the food retains the shape of the food material and uniformly includes either one or both of a thickener in a non-solvated state and microorganism which generates a viscous material inside. | 2008-12-18 |
20080311175 | Compositions and Methods for Promoting Weight Gain and Feed Conversion - The invention features compositions for administration of an oxidatively transformed carotenoid or a component thereof and methods of promoting weight gain and feed conversion efficiency therewith. | 2008-12-18 |
20080311176 | Drug Condensation Aerosols And Kits - The present invention provides novel condensation aerosols for the treatment of disease and/or intermittent or acute conditions. These condensation aerosols have little or no pyrolysis degradation products and are characterized by having an MMAD of between 1-3 microns. These aerosols are made by rapidly heating a substrate coated with a thin film of drug having a thickness of between 0.05 and 20 μm, while passing a gas over the film, to form particles of a desirable particle size for inhalation. Kits comprising a drug and a device for producing a condensation aerosol are also provided. The device contained in the kit typically, has an element for heating the drug which is coated as a film on the substrate and contains a therapeutically effective dose of a drug when the drug is administered in aerosol form, and an element allowing the vapor to cool to form an aerosol. Also disclosed, are methods for using these aerosols and kits. | 2008-12-18 |
20080311177 | Self Assembled Films for Protein and Drug Delivery Applications - Provided are systems for controlled release of proteins from decomposable thin films constructed by layer-by-layer deposition. Such films generally comprise alternating layers of polymers and proteins, and may further comprise additional layers of polyions. In some embodiments, decomposable thin films and methods of using such films allow proteins to be released over an extended period of time and/or retention of as much as 100% of function of released protein. | 2008-12-18 |
20080311178 | Gel composition and use thereof - The present invention provides a composition for a medical material or a hygiene material, which contains a large amount of an organic liquid component, has sufficient flexibility and can retain shape. The present invention provides a gel composition for a medical material or a hygiene material, which contains a liquid rubber component having a functional group capable of crosslinking reaction in a molecule and 90 parts by weight or above and 1250 parts by weight or below of an organic liquid component relative to 100 parts by weight of the rubber component, which gel composition is crosslinked. | 2008-12-18 |
20080311179 | SULFONYLPYRAZOLE AND SULFONYLPYRAZOLINE CARBOXAMIDINE DERIVATIVES AS 5-HT6 ANTAGONISTS - This invention concerns compounds of the general formula (1). | 2008-12-18 |
20080311180 | Method of Preventive On-Demand Hormonal Contraception - The invention relates to a method of hormonal female controlled on-demand contraception in which a pharmaceutical preparation comprising at least one progestogen is administered transdermally on demand and on a single occasion prior to anticipated sexual intercourse. | 2008-12-18 |
20080311181 | Serum-Stable Amphoteric Liposomes - The invention relates to amphoteric liposomal formulations which are provided with great serum stability and are suitable for the intracellular delivery of oligonucleotides. | 2008-12-18 |
20080311182 | MULTISTAGE DELIVERY OF ACTIVE AGENTS - Multistage delivery vehicles are disclosed which include a first stage particle and a second stage particle. The first stage particle is a micro or nanoparticle that contains the second stage particle. The second stage particle includes an active agent, such as a therapeutic agent or an imaging agent. The multistage delivery vehicle allows sequential overcoming or bypassing of biological barriers. The multistage delivery vehicle is administered as a part of a composition that includes a plurality of the vehicles. Methods of making the multistage delivery vehicles are also provided. | 2008-12-18 |
20080311183 | Novel Inhibitors of Pyruvate Kinase as Therapeutic Agents for Cancer - The present invention relates to compounds for the inhibition of pyruvate kinase and ATP production which are capable of inhibiting cancer cells proliferation. | 2008-12-18 |
20080311184 | METHOD FOR DEVELOPING, TESTING, AND USING ASSOCIATES OF MACROMOLECULES AND COMPLEX AGGREGATES FOR IMPROVED PAYLOAD AND CONTROLLABLE DE/ASSOCIATION RATES - This invention describes the principles and procedures suitable for developing, testing, manufacturing, and using combinations of various amphipatic, if necessary modified, macromolecules (such as polypeptides, proteins, etc.) or other chain molecules (such as suitable, e.g. partly hydrophobised, polynucleotides or polysaccharides) with the aggregates which comprise a mixture of polar and/or charged amphipats and form extended surfaces that can be freely suspended or supported. The described methods can be utilised for the optimisation of aggregates that, after association with chain molecules exerting some activity or a useful function, are suitable for the application in vitro or in vivo, for example, in the fields of drug delivery, diagnostics or bio/catalysis. As special examples, mixtures of vesicular droplets consisting of lipids loaded (associated) with insulin, interferon, interleukin, nerve growth factor, calcitonin, and an immunoglobulin, etc., are described. | 2008-12-18 |
20080311185 | Deregulated Genes and/or Processes in Inflammatory Arthritis - The invention provides means and methods for determining whether a sample is derived from an individual suffering from inflammatory arthritis or from an individual at risk of suffering there from, said method comprising measuring in said sample the level of expression of at least one gene product of a gene of table A, table B or and comparing said expression level with a reference value. Further provided is a non-human animal model comprising an altered expression of a gene of table A, table B or when compared to a reference non-human animal, and use of this model as or in an arthritis model. Further provided is an in vitro assay for screening compounds for effect on a phenotype of synovial fibroblasts. The synovial fibroblast are preferably derived from a human or non-human animal suffering from inflammatory arthritis. | 2008-12-18 |
20080311186 | Composition Having Effect on Treatment and Prevention of Dry Eye Syndrome - Provided is a composition comprising, as an active ingredient, at least one material selected from the group consisting of uridine and derivatives thereof which promote synthesis of hyaluronic acid in animal and human cell and body, and a pharmaceutical preparation containing the same. The composition and pharmaceutical preparation of the present invention is effective in the treatment and prevention of dry eye syndrome. | 2008-12-18 |
20080311187 | CRUSH RESISTAN DELAYED-RELEASE DOSAGE FORM - The invention relates to a dosage form comprising a physiologically effective amount of a physiologically active substance (A), a synthetic, semi-synthetic or natural polymer (C), optionally one or more physiologically acceptable auxiliary substances (B) and optionally a synthetic, semi-synthetic or natural wax (D), wherein the dosage form exhibits a resistance to crushing of at least 400 N and wherein under physiological conditions the release of the physiologically active substances (A) from the dosage form is at least partially delayed. | 2008-12-18 |
20080311188 | SOLID PHARMACEUTICAL COMPOSITIONS COMPRISING A SIP RECEPTOR AGONIST AND A SUGAR ALCOHOL - A solid pharmaceutical composition suitable for oral administration, comprising:
| 2008-12-18 |
20080311189 | Compositions Comprising Organometallic Molybdenum Compounds For Treating Cancer - The invention provides several molybdenum (II) complexes (see classes I and II, FIG. | 2008-12-18 |
20080311190 | Thrombin-Free Biological Adhesive and Use Thereof as a Medicament - The invention relates to a thrombin-free, fibrinogen-based biological adhesive for therapeutic use, which comprises factor VIIa and a source of calcium ions. The invention also relates to the use of the biological adhesive as a medicament, in particular as a dressing for biological tissues, wounds or biomaterials. | 2008-12-18 |
20080311191 | Multi-Layer Tablets and Bioadhesive Dosage Forms - Bioadhesives coatings increase the gastrointestinal retention time of orally-ingested medicaments. Certain bioadhesive coatings producing a fracture strength of at least 100 N/m | 2008-12-18 |
20080311192 | Enteric-Coated Glucosinolates And Beta-Thioglucosidases - The present invention relates to a particulate composition comprising enteric-coated glucosinolate and beta-thioglucosidase particles. The present invention further provides a method of converting glucosinolate to isothiocyanate in the small intestine comprising orally administering to a subject an enteric-coated chemoprotectant precursor composition comprising enteric-coated glucosinolate and beta-thioglucosinodase particles. In another aspect, uncoated glucosinolate and beta-thioglucosinodase particles may be provided in an enteric-coated capsule. Preferably, the glucosinolate is glucoraphanin and the beta-thioglucosidase is myrosinase. The enteric coating targets the compound for release in the small intestine where beta-thioglucosinodase enzyme converts glucosinolate to chemoprotectant isothiocyanate. | 2008-12-18 |
20080311193 | Sustained Release Formulation of Alprazolam - The present invention is directed towards the preparation of extended release Alprazolam formulation. The formulation thus obtained provides an efficient mode of delivery of Alprazolam in a continuous manner. | 2008-12-18 |
20080311194 | Dispersible Tablets Comprising Deferasirox - The present invention pertains to a dispersible tablet comprising (a) Compound I of the formula | 2008-12-18 |
20080311195 | BASIS PARTICLES, METHOD FOR MANUFACTURING THE SAME, AND ORALLY-DISINTEGRATING TABLET - A basis particle comprises a basic or acidic basis particle coated by a water-insoluble coating film, wherein the water-insoluble coating film contains a substance that is acidic with respect to the basic basis or basic with respect to the acidic basis. According to the basis particles (i.e., a main ingredient or an active drug)of the present invention, it is possible to temporarily adjust pH occurring in the immediate proximity of the basis particles by using a coating film, elution of the basis particles is suppressed and superior elution is exhibited without dependence on bodily pH. It is also possible to mask tastes such as the bitterness of the basis and it is possible to ingest drugs without sensing any bitterness. | 2008-12-18 |
20080311196 | All Day Rhinitic Condition Treatment Regimen - A therapeutic regimen is disclosed. The regimen includes a first pharmaceutical dosage form comprising a first therapeutically effective amount of a first antihistamine and an anticholinergic agent; and a second pharmaceutical dosage form comprising a therapeutically effective amount of a second antihistamine and an anticholinergic agent. The second antihistamine either has greater H | 2008-12-18 |
20080311197 | PROCESS FOR THE PRODUCTION OF AN ABUSE-PROOFED DOSAGE FORM - The present invention relates to a process for the production of an abuse-proofed dosage form containing, apart from one or more active ingredients with potential for abuse and optionally physiologically acceptable auxiliary substances, at least one synthetic or natural polymer (C) with a breaking strength of at least 500 N, wherein the formulation mixture is combined with a solvent for the polymer (C) at least in quantities such that the formulation mixture is at least uniformly moistened, the at least moistened composition is optionally divided into sub-portions, dried and shaped to yield the dosage form. | 2008-12-18 |
20080311200 | Controlled Slow Release Formulation of Thiamine and Use Thereof in the Treatment of Pathologies Connected to Defective Process of Learning and Memorization - The present invention relates to thiamine controlled-release pharmaceutical compositions and their use in medicine for resolving absorption defects or deficiencies of thiamine itself from the organism. Said compositions have revealed to be useful in the treatment of cerebral pathologies connected with learning and memorizing processes. In particular, said compositions have revealed to be useful in the treatment of the Alzheimer's pathology, preferably in the forms of slight-medium intensity. | 2008-12-18 |
20080311201 | MODIFIED RELEASE SOLID OR SEMI-SOLID DOSAGE FORMS - A solid or semi-solid pharmaceutical dosage form comprising non-steroidal-anti-inflammatory drugs, in particular propionic acid derivatives such as ibuprofen, along with a second active ingredient having a shorter therapeutically effective plasma concentration duration, such as phenylephrine, and methods of administering the same are provided. This method provides improved therapeutic effect, in particular pain relief along with decongestant relief, over extended time periods. | 2008-12-18 |
20080311202 | Pharmaceutical Composition Containing Donepezil Hydrochloride, Tablets Produced Therefrom and Methods for Producing the Same - A pharmaceutical composition is provided according to the invention which is suited for the production of tablets by direct compression and which contains donepezil hydrochloride of polymorphic form I. The polymorphic form I of donepezil hydrochloride in the directly compressed tablet is also stable during long storage. | 2008-12-18 |
20080311203 | Oral Formulation of Anhydrous Olanzapine Form I - The invention relates to a solid formulation for the oral administration of olanzapine that comprises a core of anhydrous olanzapine Form I or a pharmaceutically acceptable salt thereof and, optionally, pharmaceutically acceptable excipients, said core being coated with a functional polymer that acts as filmogenic agent. The method for obtaining it comprises: i) providing anhydrous olanzapine Form I or a salt thereof and, optionally, pharmaceutically acceptable excipients in solid form; ii) providing a functional polymer that acts as filmogenic agent; iii) preparing a dispersion of said functional polymer in an aqueous medium,—and applying the dispersion obtained in step iii) onto the solid form of step i). | 2008-12-18 |
20080311204 | STABLE ORAL FORMULATION CONTAINING BENZIMIDAZOLE DERIVATIVE - An enteric formulation containing at least one benzimidazole compound, said formulation containing:
| 2008-12-18 |
20080311206 | Anti-Chafing Compositions Comprising Boron Nitride - The invention in one aspect relates to an anti-chafing composition with improved efficacy, in one embodiment, comprising an effective amount of boron nitride suspended in a dermatologically acceptable carrier vehicle. Another embodiment relates to an anti-chafing composition in the form of a powder or a stick containing boron nitride. The present invention also relates to a method of inhibiting or reducing chafing to the skin by topically applying an effective amount of such anti-chafing composition to the skin or to a surface to be in contact with the skin. | 2008-12-18 |
20080311207 | Micelles and Nanoemulsions for Preventive and Reactive Treatment of Atherosclerosis - The subject invention is directed to microemulsion-based (ME) nanoparticles and methods of using same. The ME nanoparticles of the subject invention encompass self-assemblies of oil in water emulsions in the presence of at least two emulsifiers. One of the emulsifiers is a salt of a fatty acid, and the combined concentration of the at least two emulsifiers is sufficiently large to produce micelles, wherein the oil droplets are the hydrophobic core of the micelles. The subject invention also contemplates methods of modifying lipids, high density lipoprotein (HDL), and low density lipoprotein (LDL) in blood by contacting the blood with the ME nanoparticles of the subject invention. Another aspect concerns methods for treating atherosclerosis by administering the ME nanoparticles of the subject invention to a patient in need thereof. | 2008-12-18 |
20080311208 | Pharmaceutical Formulations Useful in the Treatment of Insomnia - There is provided a formulation suitable for transmucosal administration comprising a short acting hypnotic drug, which formulation provides a measurable plasma concentration of drug within 10 minutes of administration. The formulation is capable of providing sleep on demand, and preferably comprises particles of drug, for example zolpidem or a pharmaceutically-acceptable salt thereof and a mucoadhesion promoting agent, such as sodium carboxymethylcellulose, which particles of drug and mucoadhesive are presented upon the surface of larger carrier particles. | 2008-12-18 |
20080311209 | TOPICAL COMPOSITIONS COMPRISING NANOPARTICLES OF AN ISOFLAVONE - The present invention is directed to topical compositions, comprising isoflavone nanoparticle compositions. The isoflavone nanoparticle compositions contain isoflavone in the form of nanoparticles and preferably a carrier. In the topical compositions recrystallization of the isoflavone to bigger particles is avoided. | 2008-12-18 |
20080311210 | PHARMACEUTICAL COMPOSITION FOR USE AS A LAXATIVE - The invention relates to a pharmaceutical composition which is suitable in particular for use as purgative (cathartic), where the composition comprises in combination and in each case in pharmaceutically effective amounts (A) senna fruit dry extract and (B) plantago seeds ( | 2008-12-18 |
20080311211 | Easily Dispersible Lipidic Phase - The present invention relates to the use of a lipidic phase comprising an oil and a lipophilic additive (LPA), which is suitable to make an oil-in-water emulsion by application of low energy or a manual operation. The lipidic phase contains a Lipophilic Additive (LPA) which forms self-assembly structures inside the emulsion oil droplets. The aqueous phase contains a hydrophilic emulsifier and the lipidic and aqueous phases are mixed without using classical high shearing devices or homogenisers. | 2008-12-18 |
20080311212 | CRYSTALLINE ISOXAZOLE DERIVATIVE AND PHARMACEUTICAL PREPARATION THEREOF - Crystalline 3-[(1S)-1-(2-fluorobiphenyl-4-yl)ethyl]-5-{[amino(morpholin-4-yl)methylene]amino}-isoxazole that exhibits the following angle of diffraction (2θ) and relative intensity in a powder X-ray diffraction pattern, is very easy to handle and stable in a process of its formulation into a pharmaceutical preparation. | 2008-12-18 |
20080311213 | Topical Formulations Containing Sporopollenin - Topical formulation containing an active substance which is chemically or physically bound to, or encapsulated within, an exine shell of a naturally occurring spore. The active substance can be released from the exine shell on application to a living or non-living surface. The invention may be used to provide gradual release of the active substance over a period of time subsequent to application of the formulation to the surface. | 2008-12-18 |
20080311214 | Polymerized solid lipid nanoparticles for oral or mucosal delivery of therapeutic proteins and peptides - The present invention encompasses lipid nano/micro particles, which have been modified, preferably on their surface, to contain a molecule or ligand, which targets the nano/micro particles to a specific site. The invention also encompasses the use of the modified lipid nano/micro particles for the oral delivery of drugs and antigen delivery systems. | 2008-12-18 |
20080311215 | All-natural composition and method for repelling and killing insects - An all-natural composition can be used to repel or kill insects. The composition is an aqueous solution or mixture of available non-toxic ingredients. These include a weak acid to lower the pH, and one or more aromatics. The ingredients include one or more herbal essential oils, such as rosemary oil, peppermint oil, or a blend; a natural aqueous sugar extract or extracts, such as honey and/or molasses; a fragrance; and a natural weak acid solution, such as apple cider vinegar and/or lemon juice. The composition can be applied to dogs, horses, or other pets. The composition is also effective on hair and skin to combat the effects of swimming pool chlorine. | 2008-12-18 |
20080311216 | Epidermal Growth Factor Composition, A Process Therefor and Its Application - A composition for treating a wound, wherein the composition can comprise therapeutically effective amount of an epidermal growth factor and a physiologically acceptable agent, wherein the physiologically acceptable agent comprises at least one of a stabilizer, a preservative, a thickening agent, carrier/diluent, and optionally pH regulating agent and humectant. | 2008-12-18 |
20080311217 | TOPICIAL COMPOSITION FOR TREATING PAIN - Topical compositions having as the active ingredient a lipid, fatty acid ester, natural wax, sterol, or combinations thereof referred to herein as “lipophilic vehicle” or “LV” and methods of use, have been developed for the amelioration or prevention of pain or the sequelae of pain. The composition may be in the form of an ointment, cream, gel, lotion, spray, foam, paste, patch, suspension or dispersion. In the preferred embodiment, the formulation is a gel. The LV may contain a penetration enhancer, most preferably one with membrane disruptive properties. The formulation may be applied to or impregnated into a gauze, wrap, bandage, cotton-tipped stick, adhesive bandage strip, or other support wrap or medical bandage or wound cover. For example, the compositions may be are incorporated onto or into disposables such as hemorrhoid wipes, sponge, mouth guards, dental trays; needles or catheters; adult diapers; gloves, socks or wrist bands, for ease of application. The composition is applied topically to a site at or adjacent to a painful region. The composition is reapplied as necessary. Pain relief is typically obtained within minutes and lasts for periods of variable duration ranging from minutes to several hours and even, in some cases, days. The composition is variably effective to treat visceral, somatic and neuropathic pain both acute and chronic as well as muscle pain and stiffness and joint pain and stiffness. | 2008-12-18 |
20080311218 | TOPICAL COMPOSITION FOR TREATING PAIN - Topical compositions having as the active ingredient a lipid, fatty acid ester, natural wax, sterol, or combinations thereof referred to herein as “lipophilic vehicle” or “LV” and methods of use, have been developed for the amelioration or prevention of pain or the sequelae of pain. The composition may be in the form of an ointment, cream, gel, lotion, spray, foam, paste, patch, suspension or dispersion. In the preferred embodiment, the formulation is a gel. The LV may contain a penetration enhancer, most preferably one with membrane disruptive properties. The formulation may be applied to or impregnated into a gauze, wrap, bandage, cotton-tipped stick, adhesive bandage strip, or other support wrap or medical bandage or wound cover. For example, the compositions may be are incorporated onto or into disposables such as hemorrhoid wipes, sponge, mouth guards, dental trays; needles or catheters; adult diapers; gloves, socks or wrist bands, for ease of application. The composition is applied topically to a site at or adjacent to a painful region. The composition is reapplied as necessary. Pain relief is typically obtained within minutes and lasts for periods of variable duration ranging from minutes to several hours and even, in some cases, days. The composition is variably effective to treat visceral, somatic and neuropathic pain both acute and chronic as well as muscle pain and stiffness and joint pain and stiffness. | 2008-12-18 |
20080311219 | Tissue Fragment Compositions for the Treatment of Incontinence - Compositions for the treatment of incontinence are disclosed. More particularly, compositions of viable muscle tissue fragments and a carrier are disclosed. The compositions are useful in the treatment urinary and fecal incontinence. | 2008-12-18 |
20080311220 | Method for producing demineralized bone matrix easily releasing bone morphogenetic protein and method for extracting bone morphogenetic protein using demineralized bone matrix by irradiation - Disclosed is a method for producing demineralized bone matrix with improvement of releasing bone morphogenetic protein by irradiating the demineralized bone matrix, the demineralized bone matrix produced by the producing method, a method for extracting bone morphogenetic protein using the demineralized bone matrix, and the bone morphogenetic protein extracted by the extracting method. The demineralized bone matrix produced according to the present invention and the bone morphogenetic protein extracted by using the demineralized bone matrix can be advantageously used in manufacturing bone restorative implants, bone growth accelerating compositions, and/or health aids or supplementary food products. | 2008-12-18 |
20080311221 | LEWIS ACID AND OIL-SOLUBLE HYBRID PESTICIDE CONCENTRATE THAT SPONTANEOUSLY FORMS A WATER-BASED MICROEMULSION - A chemically and physically stable, transparent, hybrid pesticide concentrate is provided for preparation of a water-based microemulsion formulation. The pesticides preferably comprise an oil-soluble pesticide component, and a pesticide component having a Lewis acid pesticide portion and a pesticide complex portion. An inactive biphasic coupling agent for the pesticide ingredients includes a solvent capable of solvating the oil-soluble pesticide component, and two organic cosolvents capable of solvating the Lewis acid pesticide portion and the pesticide complex portion pesticide ingredients, respectively. A selected emulsifier is incorporated in the concentrate. A sufficient quantity of a complexing agent is provided to maintain the electrical potential of the final concentrate at a value of about −150 mV to about +150 mV. The inactive coupling agent and the complexing agent are sufficient relative to the quantity of the active pesticide ingredients to cause the concentrate to spontaneously form a microemulsion made up of particles that are less than 1μ when the concentrate is diluted with water. | 2008-12-18 |
20080311222 | System and method for applying medication to a hoof - A gel that includes a fungicide or an anti-bacterial is contained within a single dosage packet that includes a tapered nozzle end and a body. The fungicide or anti-bacterial gel is applied to the hoof of a horse by opening the packet at the tapered nozzle end and squeezing the body. The gel is then spread over the frog and sole of the hoof with a portion of the packet. The gel is heated so that it spreads to recessed areas of the hoof that can contain the bacterial and fungus infections. | 2008-12-18 |
20080311223 | INJECTABLE POLYMER-LIPID BLEND FOR LOCALIZED DRUG DELIVERY - An injectable polymer-lipid blend is provided as a localized drug delivery system for a pharmaceutically active agent. The blend may be prepared from a chitosan-based material, fatty acid and phospholipid. The chitosan-based material may be a water soluble chitosan derivative. The fatty acid may be a fatty acid or a fatty aldehyde, such as laurinaldehyde, having an acyl chain length of C8-C16. The rheological properties of the blend relates to the ratio of the components and to the acyl chain length of the fatty acid. The injectable system is well suited for the delayed release of pharmaceutically active agents in the treatment of cancer and other diseases requiring localized drug delivery. | 2008-12-18 |
20080311224 | Long-lasting mildew stain remover and method for making same - The active life of a fungicidal metal hydrochlorite is greatly enhanced by adding only small amounts of active fungicidal compounds selected from the group consisting of lithium hydrochlorite and iodopropynyl butyl carbamate. | 2008-12-18 |
20080311225 | Process and Kit for Formation of Active Hydrogen Water, Gypsum Feeder for the Formation, Active Hydrogen Forming Materials and Process for the Production of the Materials - An active hydrogen-dissolved water generator | 2008-12-18 |
20080311226 | Methods and Compositions For Improving Stool Quality - A method for improving stool quality by administering to an animal a composition comprising from about 1% to about 20% zeolite. Preferably, the zeolite is fed to ah animal as part of a food composition containing least one ingredient suitable for consumption by an animal. | 2008-12-18 |
20080311227 | Long-lasting mildew stain remover and method for making same - The fungi-preventative-over-time characteristic of a fungicidal metal hydrochlorite, as distinguished from the fungi-removal characteristic thereof, is greatly enhanced by adding thereto only small amounts of active fungicidal compounds selected from the group consisting of lithium hydrochlorite and iodopropynyl butyl carbamate. | 2008-12-18 |
20080311229 | Functional Food Composition For Treating Allergy, Natural Tea Using the Same and the Manufacturing Method Thereof - A functional food composition for treating allergy, comprising | 2008-12-18 |
20080311230 | Preparation of Artemisia to treat human cancer, autoimmune disease, IgA-Nephropathy, and to counteract weight loss in cancer patients - In human cancer, reduced appetite and weight loss are serious symptoms and are difficult to manage. These symptoms not only effect the quality of life, but also reduce the tolerance and response to anti-cancer drugs, thereby effecting the prognosis and survival to disease. These symptoms are caused, among others, by overactive immune system of the body. Anti-cancer drugs that were effective in the beginning start losing their efficacy, and are less tolerated. Also in autoimmune diseases, the immune system is overreacting. This herbal invention, based on | 2008-12-18 |
20080311231 | Broad Spectrum Non-Traditional Preservative System - Preservative compositions containing emollient solvents such as octanediol or Symdiol™ or octoxyglycerine monoesters in combination with organic acids such as alpha hydroxyl acids can be used for preventing microbial growth and spoilage in cosmetic and topical skin formulations with the added benefit of providing silky smooth texture to skin. The compositions may optionally contain an essential oil/component. These preservative compositions are odorless and colorless and small concentrations can be added to cosmetic/topical formulations to prevent bacterial, yeast and fungal growth within 24 to 48 hours after contamination. | 2008-12-18 |
20080311232 | Cooling Compounds - A cooling composition comprising at least one compound of the Formula I | 2008-12-18 |
20080311233 | Naturally Occurring Phenolic Substances Useful as Pesticides - Two phenolic compounds occurring in nature were useful in the control of some pests. Salicylaldehyde is a substance produced by some plants and some animals. A novel pest control agent is based on salicylaldehyde. It is active against caterpillars (larvae of butterflies and moths) as well as earthworms and molluscs. In combination with garlic extract it enhances the activity of such extract. An agent for the control of insects in agriculture comprises vanillin. The vanillin powder is solubilised in water for spraying onto insects infesting crops. | 2008-12-18 |
20080311234 | Oil-in-Water Emulsified Composition, and External Preparation for Skin and Cosmetics Using the Composition - An oil-in-water emulsified composition suitable for external preparation for skin and cosmetic product, which comprised 0.1 to 5% by mass of (A) lipopeptide compound derived from a microorganism such as surfactin and its analogous compound, 0.05 to 1.5% by mass of (B) xanthan gum, 25 to 70% by mass of (C) oil component and (D) water, free from non-ionic surfactants and acrylic water-soluble polymers, and is excellent in feeling upon use, moisture retention, emollient property and stability as well as environmental suitability and safety for living organisms, and external preparation for skin and cosmetic product using the composition. | 2008-12-18 |
20080311235 | Replication Tools and Related Fabrication Methods and Apparatus - Durable seamless replication tools are disclosed for replication of seamless relief patterns in desired media, for example in optical recording or data storage media. Methods of making such durable replication tools are disclosed, including preparing a recording substrate on the inner surface of a support cylinder, recording and developing a relief pattern in the substrate, creating a durable negative relief replica of the pattern, extracting the resulting durable tool sleeve from a processing cell, and mounting the tool sleeve on a mounting fixture. Apparatus are disclosed for fabricating such seamless replication tools, including systems for recording a desired relief pattern on a photosensitive layer on an inner surface of a support cylinder. Also disclosed are electrode-position cells for forming a durable tool sleeve having a desired relief pattern. The replication tool relief features may have critical dimensions down to the micron and nanometer regime. | 2008-12-18 |
20080311236 | Wedge-Lock System For Injection Molds - A wedge-lock system for injection molds, using a protrusion on one side of the mold and a mating opening and sets of wedges which act together upon mold closing to provide and maintain accurate centering of the core and cavity halves in reference to each other, to prevent core shifts and compensate for uneven thermal expansion of mold components. | 2008-12-18 |
20080311237 | Device for Processing an Edible Product - The invention relates to a device for processing an edible product in the form a viscous to pasty mass ( | 2008-12-18 |
20080311238 | Forming Die for Forming a Head on a Rope - A forming die for forming a head on a rope includes a first die block provided with a first die cavity which is provided with at least one first clamping rib, and a second die block provided with a second die cavity which is provided with at least one second clamping rib. Thus, the second clamping rib of the second die block is movable to abut the respective first clamping rib of the first die block to form an annular clamping rib which presses the head of the rope to form an annular clamping groove in a peripheral wall of the head so that the head is fixed on the rope closely by compression of the annular clamping groove to prevent the head from being detached from the rope due to a larger pulling force. | 2008-12-18 |
20080311239 | Apparatus for Blow Molding - An apparatus for blow molding wherein at least one panel insert comprises the molding surfaces of at least one mold component, the depth of at least one panel insert within a recess of the mold component is adjustable in predetermined increments while the panel insert is retained in the recess of the mold component. In one embodiment, relative depth of the panel insert is determined by abutment of stepped seating surfaces comprising at least one indexable post and stepped support surfaces comprising the insert. In a second embodiment, relative depth of the panel insert is determined by abutment of a seating surface comprising at least one indexable rod and a support surface comprising the insert, the seating surface comprising plural longitudinal flats, each flat offset from the rod centerline by different distances, relative depth of the panel insert being determined by abutment of the support surface with a selected flat. | 2008-12-18 |
20080311240 | Steam Agglomeration of Polyols - The current invention relates to steam agglomeration of polyols. In a typical embodiment steam-agglomerated sorbitol powder is provided. The steam-agglomerated sorbitol is applicable in tablets and chewing gum cores. Tablets, chewing cores and hard-coated chewing gum are disclosed as well. | 2008-12-18 |
20080311241 | Breadmaking Improver - The present invention relates to a novel breadmaking improver comprising a preferment which is acidic and an acidity regulator, and also to the use thereof in a process for preparing a baker's dough for baking which contains this improver. | 2008-12-18 |
20080311242 | VARIANT LIPOLYTIC ENZYMES - The inventors have developed improved polypeptides by substituting or deleting specified amino acids in fungal lipolytic enzymes. More particularly, the polypeptides result in a reduction of dough stickiness when they are added to a dough. The polypeptides may particularly have activity on polar lipids. | 2008-12-18 |
20080311243 | High Viscosity Beta Glucan Products And Methods of Preparation - The invention describes improved methods of preparing high concentration and high viscosity beta-glucan concentrates. More specifically, the invention describes methods wherein beta-glucan is concentrated from bran, whole grain and endosperm flours through various slurrying steps in a high concentration alcohol media utilizing various combinations of enzyme and alkali treatment steps. | 2008-12-18 |
20080311244 | Manufacturing Method for Fermented Soybeans Having Increased Gamma-Amino Butyric Acid Content - The present invention relates to a method of manufacturing fermented soybeans having increased gamma- aminobutyric acid (GABA) content, and more particularly, a method of manufacturing fermented soybeans having increased gamma-aminobutyric acid content which comprises the steps of: adding lactobacillus having glutamate decarboxylase (GAD) activity and glutamate (MSG) to soybeans; grinding and molding the mixture; and spraying starch powder mix ed with seed malt onto the surface of the molded mixture. The present invention can provide a method of manufacturing fermented soybeans including GABA, which ha s been known to accelerate sodium ion discharge through urine, so that it may lower blood pressure hypertension which may be caused from excessive consumption of salts to prevent and can produce functional paste foods satisfying people's taste and desire for health. | 2008-12-18 |
20080311245 | Enzyme-Assisted Soluble Coffee Production - The invention relates to a coffee beverage composition being devoid of significant contents of oil and insoluble particulates, comprising
| 2008-12-18 |
20080311246 | METHOD OF PRODUCING RUMINANT-EDIBLE FEED PRODUCTS - Improved methods are provided for the production of consistent quality combined and/or pH-adjusted ruminant feed products using commercial byproducts (e.g., wet distiller's grain products (WDG) and solubles syrup derived from ethanol production) of variable ingredient make-up and density. In a preferred method, continuous streams of WDG and solubles syrup ( | 2008-12-18 |
20080311247 | Packaged concentrate for preparing a bouillon, soup, sauce, gravy or for use as a seasoning, the concentrate comprising konjac mannan - Packaged concentrates in jelly form for preparing a bouillon, broth, soup, sauce, gravy or for use as a seasoning, which concentrates comprises 20-80% water, 0.5-60% taste imparting components, 15-40% salt, and a gelling agent comprising konjac mannan. | 2008-12-18 |
20080311248 | Packaged concentrate for preparing a bouillon, soup,sauce, gravy or for use as seasoning, the concentrate comprising modified starch. - Packaged concentrates in jelly form for preparing a bouillon, broth, soup, sauce, gravy or for use as a seasoning, which concentrates comprises 20-80% water, 0.5-60% taste imparting components, 15-40% salt, and 15-30% of a modified starch. | 2008-12-18 |
20080311249 | Packaged concentrate for preparing a bouillon, soup, sauce, gravy or for use as a seasoning, the concentrate comprising xanthan and tara gum - Packaged concentrates in jelly form for preparing a bouillon, broth, soup, sauce, gravy or for use as a seasoning, which concentrates comprises 20-80% water, 0.5-60% taste imparting components, 15-40% salt, and a gelling agent comprising xanthan and tara gum. | 2008-12-18 |
20080311250 | Packaged concentrate for preparing a bouillon, soup, sauce, gravy or for use as a seasoning, the concentrate comprising xanthan and cassia gum - Packaged concentrates in jelly form for preparing a bouillon, broth, soup, sauce, gravy or for use as a seasoning, which concentrates comprises 20-80% water, 0.5-60% taste imparting components, 15-40% salt, and a gelling agent comprising xanthan and cassia gum. | 2008-12-18 |
20080311251 | Packaged concentrate for preparing a bouillon, soup, sauce, gravy or for use as a seasoning, the concentrate comprising xanthan and guar gum - Packaged concentrates in jelly form for preparing a bouillon, broth, soup, sauce, gravy or for use as a seasoning, which concentrates comprises 20-80% water, 0.5-60% taste imparting components, 15-40% salt, and a gelling agent comprising xanthan and guar gum. | 2008-12-18 |
20080311252 | Chocolate based dietary supplement product or sweet beverage product - A cocoa based dietary supplement or functional food beverage product is revealed with enhanced flavor and health characteristics. Cocoa sources are combined with extracts of the fruit of Lo Han and/or extracts from the leaves of | 2008-12-18 |
20080311253 | GENDER-SPECIFIC HERBAL AND MINERAL SUPPLEMENT DRINKS - Gender-specific trace mineral-containing drink compositions for nutritional supplementation are described. Both the drinks intended for males and the drinks intended for females contain minerals, vitamins, flavors, and water. The drinks intended for males contain an extract of maca, whereas the drinks intended for females contain an extract of vitex. | 2008-12-18 |
20080311254 | Extinguisher Food Product and Method of Manufacture - An extinguisher food product is provided in which the intensity level of each piece of food product is controlled. The intensity level of each piece may be a sourness level or a spiciness level. The extinguisher food product may be a hard candy, fruit snack or other snack products. | 2008-12-18 |
20080311255 | Powder Compositions - Powder compositions having particle average diameters of about 50 to 500 microns which comprise droplets containing a long chain polyunsaturated fatty acid (I.C-PUFA) embedded in a matrix of a modified polysaccharide and wherein the particles are characterized by a surface oil content of less than 0.5% (w/w), a process for their manufacture and their applications in the preparation of food with increased nutritional value. | 2008-12-18 |
20080311256 | METHOD AND APPARATUS FOR THE AUTOMATIC STUFFING OF MEAT PRODUCTS INTO A DOUBLE CASING COMPRISING A SHEET AND A NET - A multi-perforated collagen film is provided on rolls or in the form of sheets for use as a food wrapping. The perforations and made by laser of substantially circular shape with an average ellipticity of less than 0.17 and the holes are spaced with respect to their nearest neighbors by 3 to 14 mm, thus allowing the escape of air or steam trapped between the film and the food wrapped in the film. The film still has sufficient mechanical strength and extensibility to be able to stand the food processing steps in the manufacture of cooked ham or in comparable operations under industrial conditions. | 2008-12-18 |
20080311257 | Use of Cocoa Butter in Culinary Preparations - The present invention relates to the use of cocoa butter as a replacement for dairy butter and oils in culinary preparations, in particular in the following applications: cooking, seasoning, preparation of emulsions and of doughs (tart dough, fritter dough and the like), preservation of foods, etc. | 2008-12-18 |